Literature DB >> 6209209

Adjuvant effect of bacterial LPS and/or alum precipitation in responses to polysaccharide and protein antigens.

I J Seppälä, O Mäkelä.   

Abstract

A conjugate of a hapten (NIP) and a strongly antigenic protein chicken gamma globulin (CGG), when injected in soluble form into mice, induced weak primary responses, as weak as responses induced by conjugates of NIP (or other haptens) to polysaccharides Ficoll or alpha (-1-6) dextran. Mean concentrations of anti-hapten antibodies on day 14 varied within the range of 37-105 micrograms/ml (C57BL mice) or 14-38 micrograms/ml (CBA mice). The NIP-protein conjugate administered in alum-precipitated form induced 100 times higher primary antibody responses. Alum-precipitation of NIP-Ficoll made it a modestly stronger antigen than soluble NIP-Ficoll. When lipopolysaccharide (LPS) was injected together with any of the soluble antigens, the mice produced plenty of anti-hapten antibodies regardless of whether the antigen was hapten-polysaccharide or hapten-protein conjugate. Concentrations on day 14 varied from around 400 micrograms/ml to approximately 1600 micrograms/ml. LPS had a similar adjuvant effect on antidextran responses. LPS alone induced a polyclonal immunoglobulin production, and the immunoglobulin produced included 'anti-NIP' or 'anti-dextran' detectable in the solid phase antibody assay. These 'antibodies' induced by LPS alone were almost totally mercapto-ethanol-sensitive and poorly detectable by Farr assay or the bacteriophage assay. The response to the LPS+antigen combination was specific for the antigen and included both mercapto-ethanol-sensitive and resistant antibodies.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6209209      PMCID: PMC1454889     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  28 in total

1.  Lipopolysaccharide-induced suppression of the primary immune response to a thymus-dependent antigen.

Authors:  U Persson
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

2.  Modification of bacteriophage with hapten-epsilon-aminocaproyl-N-hydroxysuccinimide esters; increased sensitivity for immunoassay.

Authors:  M Becker; O Mäkelä
Journal:  Immunochemistry       Date:  1975-04

3.  Studies on the control of antibody synthesis. V. Effect of nonspecific modification of the magnitude of the immune response on the affinity of the antibody synthesized.

Authors:  J Mond; Y T Kim; G W Siskind
Journal:  J Immunol       Date:  1974-03       Impact factor: 5.422

4.  Affinity requirements for antibody assays mapped by monoclonal antibodies.

Authors:  F Péterfy; P Kuusela; O Mäkelä
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

5.  Immunosuppressive effect of bacterial lipopolysaccharide on antibody response.

Authors:  M Nakano; M J Tanabe; T Saito; T Shimizu
Journal:  Jpn J Microbiol       Date:  1976-02

6.  Fine specificity of the immune response to oxazolones III. Antibodies but not contact sensitivity specific for 2-furyloxazolone are controlled by an Igh-V gene in the mouse.

Authors:  O Mäkelä; A Matoso-Ferreira; M Kaartinen
Journal:  Eur J Immunol       Date:  1983-12       Impact factor: 5.532

7.  Assessing B cell diversification by antigen receptor and precursor cell analysis.

Authors:  N R Klinman; A R Pickard; N H Sigal; P J Gearhart; E S Metcalf; S K Pierce
Journal:  Ann Immunol (Paris)       Date:  1976 Jun-Jul

8.  The use of bacterial lipopolysaccharides to show that two signals are required for the induction of antibody synthesis.

Authors:  J Watson; E Trenkner; M Cohn
Journal:  J Exp Med       Date:  1973-09-01       Impact factor: 14.307

9.  Inheritance of antibody specificity V. Anti-2-phenyloxazolone in the mouse.

Authors:  O Näkelä; M Kaartinen; J L Pelkonen; K Karjalainen
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

10.  Subclass restriction of murine antibodies. II. The IgG plaque-forming cell response to thymus-independent type 1 and type 2 antigens in normal mice and mice expressing an X-linked immunodeficiency.

Authors:  J Slack; G P Der-Balian; M Nahm; J M Davie
Journal:  J Exp Med       Date:  1980-04-01       Impact factor: 14.307

View more
  12 in total

1.  Co-administration of toll-like receptor (TLR)-3 and 4 ligands augments immune response to Newcastle disease virus (NDV) vaccine in chicken.

Authors:  T R Kannaki; E Priyanka; M R Reddy
Journal:  Vet Res Commun       Date:  2019-08-24       Impact factor: 2.459

2.  Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice.

Authors:  J R Hiernaux; P W Stashak; J L Cantrell; J A Rudbach; P J Baker
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

3.  Applications of polysaccharides. Patents and literature.

Authors:  R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1986-04       Impact factor: 2.926

4.  Biomimetic antigenic nanoparticles elicit controlled protective immune response to influenza.

Authors:  Dustin P Patterson; Agnieszka Rynda-Apple; Ann L Harmsen; Allen G Harmsen; Trevor Douglas
Journal:  ACS Nano       Date:  2013-04-10       Impact factor: 15.881

5.  A vaccine conjugate of 'ISCAR' immunocarrier and peptide epitopes of the E7 cervical cancer-associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants.

Authors:  R W Tindle; S Croft; K Herd; K Malcolm; A F Geczy; T Stewart; G J Fernando
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

6.  Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response.

Authors:  Cristina L Swanson; Timothy J Wilson; Pamela Strauch; Marco Colonna; Roberta Pelanda; Raul M Torres
Journal:  J Exp Med       Date:  2010-06-21       Impact factor: 14.307

Review 7.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

8.  Caveolin-1-dependent nanoscale organization of the BCR regulates B cell tolerance.

Authors:  Susana Minguet; Kathrin Kläsener; Anna-Maria Schaffer; Gina J Fiala; Teresa Osteso-Ibánez; Katrin Raute; Inmaculada Navarro-Lérida; Frederike A Hartl; Maximilian Seidl; Michael Reth; Miguel A Del Pozo
Journal:  Nat Immunol       Date:  2017-08-14       Impact factor: 25.606

9.  Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.

Authors:  J Grzybowski; E A Trafny; J Wrembel-Wargocka; J Patzer; D Dzierzanowska; I Zawistowska-Marciniak; M Kłos
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 11.677

10.  In vivo protective effect of lipopolysaccharide against Pseudomonas aeruginosa exotoxin A in mice.

Authors:  T Zehavi-Willner; A Barnea; M Pinto
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.